Literature DB >> 7584097

Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.

M A Stockschläder1, F G Schuening, T C Graham, R Storb.   

Abstract

We studied transplantation of retrovirus vector transduced canine keratinocytes to determine whether keratinocytes could persist and express the transferred gene after superficial transplantation to full-thickness wounds of dogs, a large random-bred model for gene transfer studies. Canine keratinocytes were transduced by co-cultivation with PA317 retrovirus packaging cells which produced helper-free amphotropic retroviral vectors (LZSN and LNPOZ) encoding the genes for beta-galactosidase (beta-gal) and neomycin phosphotransferase (neo). Efficient transfer and expression of the two genes could be demonstrated in confluent keratinocyte cultures for both vectors. When transduced keratinocytes were grown in organotypic cultures on a collagen matrix containing autologous dermal fibroblasts at the air-liquid interface, the cultures showed well-organized and defined epidermal cell layers and several markers of terminal differentiation, including the presence of keratohyalin granules and a multilayered stratum corneum. To determine whether the transferred beta-gal gene was also expressed in vivo, we performed autologous transplantation of transduced keratinocytes onto full-thickness wounds of dogs. beta-Gal expressing keratinocytes could be demonstrated in situ in the regenerating epidermis 2 weeks after transplantation. We conclude that keratinocytes can be efficiently transduced by retroviral vectors, that retroviral transduction does not interfere with proliferation or differentiation, and that transduced keratinocytes express the transferred gene after transplantation to full-thickness skin wounds of dogs. Keratinocytes thus seem to be good target cells for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7584097

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.

Authors:  Ulrich Kuhn; Atsushi Terunuma; Wolfgang Pfutzner; Ruth Ann Foster; Jonathan C Vogel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.

Authors:  S Ghazizadeh; J M Carroll; L B Taichman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 3.  Cultivation of human keratinocyte stem cells: current and future clinical applications.

Authors:  G Pellegrini; S Bondanza; L Guerra; M De Luca
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

4.  Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.

Authors:  Soosan Ghazizadeh; Richard S Kalish; Lorne B Taichman
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

5.  PTD-mediated loading of tumor-seeking lymphocytes with prodrug-activating enzymes.

Authors:  Qin Yang; Stine K Larsen; Zhibao Mi; Paul D Robbins; Per H Basse
Journal:  AAPS J       Date:  2008-12-23       Impact factor: 4.009

6.  Clonal analysis of stably transduced human epidermal stem cells in culture.

Authors:  M B Mathor; G Ferrari; E Dellambra; M Cilli; F Mavilio; R Cancedda; M De Luca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.